Trial intelligence / Profile preview

Omeprazole PK/PD by CYP2C19 Genotype

NCT02299687Phase 1Completed

Sponsor
Seoul National University Hospital
Start
Sep 2014
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, open-label trial of omeprazole in gastric ulcer (3 arms), sponsored by Seoul National University Hospital. Primary endpoint: mean and median Intragastric PH at 24 hour. Started Sep 2014; status: completed.

02

Drugs

omeprazole
03

Conditions

gastric ulcer

Beyond the preview

Go deeper on NCT02299687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02299687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call